WBR0246: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{Rim}} | |QuestionAuthor={{Rim}} (Reviewed by {{AJL}} and {{YD}}) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
Line 21: | Line 21: | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|Prompt=A 62-year-old | |Prompt=A 62-year-old man presents to the physician's office with complaints of worsening abdominal pain over the past four months. The pain is described as dull and localized in the mid-epigastric region. The patient denies any association between his pain and food intake or posture. Upon further questioning, he describes symptoms of increasing fatigue and recent unintentional weight loss. An abdominal CT scan shows a gastric mass, and an endoscopy-guided biopsy of the mass reveals clusters of thin, elongated, spindle cells. Immunohistochemistry of this patient's tumor is most likely to reveal expression of which protein? | ||
|Explanation=The patient's symptoms of epigastric pain, fatigue, and weight loss, | |Explanation=Gastrointestinal stromal tumor (GIST) is a rare non-epithelial neoplasm of the GI tract, the mesentary, or the omentum. The majority of GIST tumors are spindle cell tumors that may be either malignant or benign. Most stromal tumors stain positively for C-Kit/CD117 (>90%), CD34, muscle-specific actin, smooth muscle actin, S-100, and desmin. Patients with GIST may be asymptomatic or have non-specific GI symptoms. This patient's symptoms of dull epigastric pain, fatigue, and weight loss, in conjunction with the CT finding of a mass in the stomach, are suggestive of malignancy. Characteristically, the pathogenesis of GIST tumors involves a gain-of-function mutation in the ''KIT'' proto-oncogene, which encodes a transmembrane receptor for stem cell factor that includes a tyrosine kinase component in its intracytoplasmic region. | ||
|AnswerA=C-kit | |AnswerA=C-kit | ||
|AnswerAExp=[[C-kit]] | |AnswerAExp=Expression of [[C-kit]] is associated with [[GIST]]. | ||
|AnswerB=Ret | |AnswerB=Ret | ||
|AnswerBExp= | |AnswerBExp=Expression of Ret protein is associated with multiple endocrine neoplasia (MEN) 2A and 2B syndromes. | ||
|AnswerC=Abl | |AnswerC=Abl | ||
|AnswerCExp= | |AnswerCExp=Expression of Ab1 is often associated with chronic myelogenous leukemia (CML). | ||
|AnswerD=Ras | |AnswerD=Ras | ||
|AnswerDExp= | |AnswerDExp=Expression of Ras is associated with colon adenocarcinoma. | ||
|AnswerE=C-myc | |AnswerE=C-myc | ||
|AnswerEExp=[[C-myc]] is associated with [[Burkitt's lymphoma]]. | |AnswerEExp=Expression of [[C-myc]] is associated with [[Burkitt's lymphoma]]. | ||
|EducationalObjectives= | |EducationalObjectives=Gastrointestinal stromal tumor (GIST) is a rare non-epithelial neoplasm of the GI tract, the mesentary, or the omentum. The majority of GIST tumors are spindle cell tumors that may be either malignant or benign. Most stromal tumors stain positively for C-Kit/CD117 | ||
|References=Din OS, Woll PJ. Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate. Ther Clin Risk Manag. 2008;4(1):149-62.<br> | |||
First Aid 2014 page 232 | |||
|RightAnswer=A | |RightAnswer=A | ||
|WBRKeyword=Cancer, GIST, Gastrointestinal stromal tumor, | |WBRKeyword=Cancer, GIST, Gastrointestinal stromal tumor, Marker, Mutation, KIT, C-kit, Proto-oncogene, Immunohistochemistry | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} |
Revision as of 21:30, 7 November 2014
Author | [[PageAuthor::Rim Halaby, M.D. [1] (Reviewed by Alison Leibowitz [2] and Yazan Daaboul, M.D.)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pathology |
Sub Category | SubCategory::Gastrointestinal |
Prompt | [[Prompt::A 62-year-old man presents to the physician's office with complaints of worsening abdominal pain over the past four months. The pain is described as dull and localized in the mid-epigastric region. The patient denies any association between his pain and food intake or posture. Upon further questioning, he describes symptoms of increasing fatigue and recent unintentional weight loss. An abdominal CT scan shows a gastric mass, and an endoscopy-guided biopsy of the mass reveals clusters of thin, elongated, spindle cells. Immunohistochemistry of this patient's tumor is most likely to reveal expression of which protein?]] |
Answer A | AnswerA::C-kit |
Answer A Explanation | [[AnswerAExp::Expression of C-kit is associated with GIST.]] |
Answer B | AnswerB::Ret |
Answer B Explanation | AnswerBExp::Expression of Ret protein is associated with multiple endocrine neoplasia (MEN) 2A and 2B syndromes. |
Answer C | AnswerC::Abl |
Answer C Explanation | AnswerCExp::Expression of Ab1 is often associated with chronic myelogenous leukemia (CML). |
Answer D | AnswerD::Ras |
Answer D Explanation | AnswerDExp::Expression of Ras is associated with colon adenocarcinoma. |
Answer E | AnswerE::C-myc |
Answer E Explanation | [[AnswerEExp::Expression of C-myc is associated with Burkitt's lymphoma.]] |
Right Answer | RightAnswer::A |
Explanation | [[Explanation::Gastrointestinal stromal tumor (GIST) is a rare non-epithelial neoplasm of the GI tract, the mesentary, or the omentum. The majority of GIST tumors are spindle cell tumors that may be either malignant or benign. Most stromal tumors stain positively for C-Kit/CD117 (>90%), CD34, muscle-specific actin, smooth muscle actin, S-100, and desmin. Patients with GIST may be asymptomatic or have non-specific GI symptoms. This patient's symptoms of dull epigastric pain, fatigue, and weight loss, in conjunction with the CT finding of a mass in the stomach, are suggestive of malignancy. Characteristically, the pathogenesis of GIST tumors involves a gain-of-function mutation in the KIT proto-oncogene, which encodes a transmembrane receptor for stem cell factor that includes a tyrosine kinase component in its intracytoplasmic region. Educational Objective: Gastrointestinal stromal tumor (GIST) is a rare non-epithelial neoplasm of the GI tract, the mesentary, or the omentum. The majority of GIST tumors are spindle cell tumors that may be either malignant or benign. Most stromal tumors stain positively for C-Kit/CD117 |
Approved | Approved::Yes |
Keyword | WBRKeyword::Cancer, WBRKeyword::GIST, WBRKeyword::Gastrointestinal stromal tumor, WBRKeyword::Marker, WBRKeyword::Mutation, WBRKeyword::KIT, WBRKeyword::C-kit, WBRKeyword::Proto-oncogene, WBRKeyword::Immunohistochemistry |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |